Protocols is the new name of Kokorology’s Journal app. Existing accounts, subscriptions and purchases continue to work.
Daily protocol follow-through
Morning and evening check-ins place self-reported body signals next to everyday routines and Anchor tasks. A check-in is context, not a diagnosis or proof that nervous-system regulation makes every intervention work.
Supplement tracking
Upload and review supplement labels, combine ingredients across products, inspect timing and reference-limit flags, and keep a monthly review. Unknown amounts or vitamin forms remain explicitly incomplete rather than being guessed. Flags do not provide personalised medical clearance.
Practitioner sharing
Create and revoke a link to your supplement stack. Broader shared coach–doctor workspaces remain a planned capability. Coaches support implementation within their qualifications; medical decisions stay with your clinician.
Existing access
Digital monthly access is configured at €25/month; annual digital access at €240/year. The full Daily Practice Hacks library remains included. Existing Journal URLs and purchase references are unchanged.
Evidence, not promises
60.2% of US adults aged 20+ used a dietary supplement; 38.7% used two or more in the past 30 days. CDC / NCHS Data Brief 561, May 2026. NHANES August 2021–August 2023. These figures describe use, not harm or Protocols outcomes.
Supplement use is common. Overlap matters.
Thom et al. reported a 1.08-day between-group improvement in self-reported medication-adherent days per week with primary-care health coaching. 2015, 12-month trial. Evidence for that coaching intervention, not evidence that Kokorology improves adherence.
Follow-through can benefit from support.
The STEP-1 exploratory DXA substudy reported a 9.7% reduction in lean body mass in the semaglutide group at 68 weeks. 2021; 140 scanned participants. Lean body mass is not the same as skeletal muscle or strength. This does not establish that non-adherence caused the change.
GLP-1 care needs more than a weight readout.
A 2025 multi-society advisory describes nutrition, physical activity and individualised support during GLP-1 treatment. Clinical guidance, not a trial of Protocols. Medication and treatment decisions remain with the prescriber.
Nutrition and movement belong beside clinical care.
Find a protocol or evidence page
Search protocols, supplements and evidence.